Journal
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Volume 34, Issue 11, Pages 829-838Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2013.0136
Keywords
-
Funding
- National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics
Ask authors/readers for more resources
Interferons (IFNs) are generally considered antiviral cytokines, yet the newly discovered IFN-lambda 4 is linked with the failure to clear hepatitis C virus (HCV) infection either spontaneously or in response to treatment. IFN-lambda 4 can be generated only by individuals who carry the IFNL4-Delta G allele (rs368234815), which is the strongest known host factor for predicting clearance of HCV. The ancestral IFNL4-Delta G allele is the major variant in Africans while the minor variant in Asians, suggesting very strong negative genetic selection for this allele-most likely driven by an infectious agent other than HCV. IFN-lambda 4 most closely resembles IFN-lambda 3, but these proteins share only 29% amino-acid identity, and, in contrast to IFN-lambda 3, IFN-lambda 4 is only weakly secreted. Nevertheless, IFN-lambda 4 signals through the IFN-lambda receptor complex and induces expression of IFN-stimulated genes via the Janus kinase-signal transducer and activator of transcription signaling pathway. Although the IFNL4-Delta G variant is strongly associated with the failure to clear HCV infection, HCV-infected patients who carry this allele have lower baseline HCV RNA levels in the absence of treatment. Resolving the paradoxical functions of IFN-lambda 4, which appears to induce antiviral activity yet impair effective clearance of HCV, may yield critical new insights into the immunologic response to HCV infection and IFN biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available